Buffa Vanessa, Walz Carlo, Meyners Christian, Zheng Min, Oki Sugiarto Wisely, Repity Maximilian, Achaq Hanaa, Brudy Christian, Spiske Moritz, Cica Matijas, Hausch Felix
Department of Chemistry and Biochemistry Clemens-Schöpf-Institute, Technical University Darmstadt, Peter-Grünberg-Straße 4, 64287, Darmstadt, Germany.
Center for Synthetic Biology, Technical University Darmstadt.
Angew Chem Int Ed Engl. 2025 Mar 3;64(10):e202418512. doi: 10.1002/anie.202418512. Epub 2025 Feb 9.
Macrocycles are abundantly used by nature to enable cell-permeable bioactive molecules. Synthetic non-peptidic macrocycles are also increasingly considered as modalities for difficult-to-bind proteins but guidelines for macrocyclization are only beginning to emerge. Macrocycles are thought to constrain the available conformations but also to allow for residual flexibility, the latter being poorly understood. Here we show that even medium-sized macrocycles display an unexpected high conformational plasticity, even when bound to their protein target. Minor modification of the linker region of macrocycles can shift the conformational ensemble to distinct conformational subclasses, each constituting distinct three-dimensional scaffolds for further optimization. This led to several new ligands with improved affinity and beneficial physicochemical parameters for the FK506-binding protein 51, a promising target for depression, obesity and chronic pain. Importantly, none of the beneficial modifications could have been identified by classical medicinal chemistry as they only work in the macrocyclic context. Our results show that macrocyclization can do more than keeping loose ends together but rather provide a platform for multiple series of macrocycles with distinct binding modes.
大环化合物在自然界中被广泛用于实现细胞可渗透的生物活性分子。合成非肽大环化合物也越来越被视为针对难以结合的蛋白质的一种方式,但大环化的指导原则才刚刚开始出现。人们认为大环化合物会限制可用的构象,但也允许有残余的灵活性,而后者的理解还很不足。在这里,我们表明,即使是中等大小的大环化合物,即使与它们的蛋白质靶点结合时,也表现出意想不到的高构象可塑性。大环化合物连接区的微小修饰可以将构象集合转移到不同的构象亚类,每个亚类都构成用于进一步优化的独特三维支架。这产生了几种对FK506结合蛋白51具有更高亲和力和有益物理化学参数的新配体,FK506结合蛋白51是治疗抑郁症、肥胖症和慢性疼痛的一个有前景的靶点。重要的是,经典药物化学无法识别任何有益的修饰,因为它们只在大环环境中起作用。我们的结果表明,大环化的作用不仅仅是将松散的末端连接在一起,而是为具有不同结合模式的多个大环化合物系列提供一个平台。